Safety of antihistamines during pregnancy and lactation

Canadian Family Physician

Volumn 56, Issue 5, 2010, Pages 427-429

  So, Miranda ^a   Bozzo, Pina ^a   Inoue, Miho ^a   Einarson, Adrienne ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; DESLORATADINE; FEXOFENADINE; HYDROXYZINE; LORATADINE; TERFENADINE;

ABSENCE OF SIDE EFFECTS; ALLERGIC RHINITIS; BREAST FEEDING; BREAST MILK; CLINICAL TRIAL; DROWSINESS; DRUG EXPOSURE; DRUG SAFETY; DRUG TARGETING; FETUS RISK; HUMAN; INFANT; LACTATION; NONHUMAN; PREGNANCY; PREGNANCY OUTCOME; REVIEW; RISK ASSESSMENT; RISK FACTOR;

BREAST FEEDING; FEMALE; FETUS; HISTAMINE ANTAGONISTS; HUMANS; HYPERSENSITIVITY; INFORMED CONSENT; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 77952997805     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Incaudo GA, Takach P. The diagnosis and treatment of allergic rhinitis during pregnancy and lactation. Immunol Allergy Clin North Am 2006;26(1):137-154 (Pubitemid 43144616)
2. Buhimschi CS, Weiner CP. Medications in pregnancy and lactation: part 2. Drugs with minimal or unknown human teratogenic effect. Obstet Gynecol 2009;113(2 Pt 1):417-432
3. Gilbert C, Mazzotta P, Loebstein R, Koren G. Fetal safety of drugs used in the treatment of allergic rhinitis: a critical review. Drug Saf 2005;28(8):707-719
4. Seto A, Einarson T, Koren G. Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis. Am J Perinatol 1997;14(3):119-124
5. Einarson A, Bailey B, Jung G, Spizzirri D, Baillie M, Koren G. Prospective controlled study of hydroxyzine and cetirizine in pregnancy. Ann Allergy Asthma Immunol 1997;78(2):183-186
6. Källén B. Use of antihistamine drugs in early pregnancy and delivery outcome. J Matern Fetal Neonatal Med 2002;11(3):146-152
7. NATO Advanced Research Workshop on "Drugs in pregnancy: consensus conference on teratogen information services," Prague, 16-18 April 2004 [Abstract]. Reprod Toxicol 2004;19(2):258.
8. Weber-Schoendorfer C, Schaefer C. The safety of cetirizine during pregnancy. A prospective observational cohort study. Reprod Toxicol 2008;26(1):19-23. Epub 2008 May 13.
9. Allegra [product monograph]. Laval, QC: Sanofi-Aventis Canada Inc; 2006.
10. Aerius [product monograph]. Montreal, QC: Schering-Plough Canada Inc; 2006.
11. Moretti ME, Caprara D, Coutinho CJ, Bar-Oz B, Berkovitch M, Addis A, et al. Fetal safety of loratadine use in the first trimester of pregnancy: a multicentre study. J Allergy Clin Immunol 2003;111(3):479-483 (Pubitemid 36337865)
12. Diav-Citrin O, Shechtman S, Aharonovich A, Moerman L, Arnon J, Wajnberg R, et al. Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled study. J Allergy Clin Immunol 2003;111(6):1239-1243 (Pubitemid 36683676)
13. Kallen B, Olausson PO. Monitoring of maternal drug use and infant congenital malformations. Does loratadine cause hypospadias? Int J Risk Saf Med 2001;14:115-119 (Pubitemid 35024885)
14. Gilboa SM, Strickland MJ, Olshan AF, Werler MM, Correa A; National Birth Defects Prevention Study. Use of antihistamine medications during early pregnancy and isolated major malformations. Birth Defects Res A Clin Mol Teratol 2009;85(2):137-150
15. Schwarz EB, Moretti ME, Nayak S, Koren G. Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta-analysis. Drug Saf 2008;31(9):775-788
16. Rindi V. La eliminazione degli antistaminici di sintesi con il latte e l'azione latto-goga de questi. Riv Ital Ginecol 1951;34:147-157
17. Findlay JW, Butz RF, Sailstad JM, Warren JT, Welch RM. Pseudoephedrine and triprolidine in plasma and breast milk of nursing mothers. Br J Clin Pharmacol 1984;18(6):901-906
18. Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol 1993;168(5):1393-1399 (Pubitemid 23153278)
19. Hilbert J, Radwanski E, Affrime MB, Perentesis G, Symchowicz S, Zampaglione N. Excretion of loratadine in human breast milk. J Clin Pharmacol 1988;28(3):234-239 (Pubitemid 19014771)
20. Lucas BD Jr, Purdy CY, Scarim SK, Benjamin S, Abel SR, Hilleman DE. Terfenadine pharmacokinetics in breast milk in lactating women. Clin Pharmacol Ther 1995;57(4):398-402.